Luke Sergott
Stock Analyst at Barclays
(2.18)
# 2,894
Out of 4,983 analysts
309
Total ratings
42.36%
Success rate
-5.24%
Average return
Main Sectors:
Stocks Rated by Luke Sergott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMO Thermo Fisher Scientific | Upgrades: Overweight | $490 → $550 | $480.74 | +14.41% | 27 | Sep 11, 2025 | |
| A Agilent Technologies | Maintains: Equal-Weight | $125 | $127.19 | -1.72% | 11 | Aug 29, 2025 | |
| NTRA Natera | Maintains: Overweight | $190 → $210 | $175.01 | +19.99% | 4 | Aug 8, 2025 | |
| TXG 10x Genomics | Maintains: Overweight | $13 → $15 | $13.13 | +14.24% | 13 | Aug 8, 2025 | |
| FTRE Fortrea Holdings | Maintains: Underweight | $5 → $6 | $10.06 | -40.36% | 11 | Aug 7, 2025 | |
| EXAS Exact Sciences | Maintains: Overweight | $65 → $55 | $52.94 | +3.89% | 6 | Aug 7, 2025 | |
| CRL Charles River Laboratories International | Maintains: Equal-Weight | $155 → $165 | $151.60 | +8.84% | 8 | Aug 7, 2025 | |
| BRKR Bruker | Maintains: Overweight | $46 → $43 | $33.26 | +29.28% | 5 | Aug 4, 2025 | |
| AVTR Avantor | Maintains: Overweight | $15 → $13 | $12.71 | +2.28% | 25 | Aug 4, 2025 | |
| ILMN Illumina | Maintains: Underweight | $85 → $90 | $101.48 | -11.31% | 19 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $90 | $83.90 | +7.27% | 1 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $155 → $180 | $173.13 | +3.97% | 20 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $300 → $450 | $490.77 | -8.31% | 2 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $185 | $186.81 | -0.97% | 23 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2 → $1.5 | $1.23 | +21.95% | 5 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $16.30 | -20.25% | 21 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $215 → $225 | $190.47 | +18.13% | 40 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $245 | $258.35 | -5.17% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $150 | $119.75 | +25.26% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $55 | $45.60 | +20.61% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $1,325 | $1,276.10 | +3.83% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $11 → $14 | $11.55 | +21.21% | 17 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 → $60 | $55.40 | +8.30% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $400 → $350 | $303.08 | +15.48% | 18 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $45 | $27.08 | +66.17% | 17 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $110 | $85.28 | +28.99% | 9 | Apr 10, 2025 |
Thermo Fisher Scientific
Sep 11, 2025
Upgrades: Overweight
Price Target: $490 → $550
Current: $480.74
Upside: +14.41%
Agilent Technologies
Aug 29, 2025
Maintains: Equal-Weight
Price Target: $125
Current: $127.19
Upside: -1.72%
Natera
Aug 8, 2025
Maintains: Overweight
Price Target: $190 → $210
Current: $175.01
Upside: +19.99%
10x Genomics
Aug 8, 2025
Maintains: Overweight
Price Target: $13 → $15
Current: $13.13
Upside: +14.24%
Fortrea Holdings
Aug 7, 2025
Maintains: Underweight
Price Target: $5 → $6
Current: $10.06
Upside: -40.36%
Exact Sciences
Aug 7, 2025
Maintains: Overweight
Price Target: $65 → $55
Current: $52.94
Upside: +3.89%
Charles River Laboratories International
Aug 7, 2025
Maintains: Equal-Weight
Price Target: $155 → $165
Current: $151.60
Upside: +8.84%
Bruker
Aug 4, 2025
Maintains: Overweight
Price Target: $46 → $43
Current: $33.26
Upside: +29.28%
Avantor
Aug 4, 2025
Maintains: Overweight
Price Target: $15 → $13
Current: $12.71
Upside: +2.28%
Illumina
Aug 1, 2025
Maintains: Underweight
Price Target: $85 → $90
Current: $101.48
Upside: -11.31%
Aug 1, 2025
Initiates: Overweight
Price Target: $90
Current: $83.90
Upside: +7.27%
Jul 25, 2025
Maintains: Equal-Weight
Price Target: $155 → $180
Current: $173.13
Upside: +3.97%
Jul 23, 2025
Maintains: Equal-Weight
Price Target: $300 → $450
Current: $490.77
Upside: -8.31%
Jul 23, 2025
Maintains: Equal-Weight
Price Target: $165 → $185
Current: $186.81
Upside: -0.97%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $2 → $1.5
Current: $1.23
Upside: +21.95%
Jun 24, 2025
Maintains: Overweight
Price Target: $15 → $13
Current: $16.30
Upside: -20.25%
Jun 24, 2025
Maintains: Overweight
Price Target: $215 → $225
Current: $190.47
Upside: +18.13%
Jun 24, 2025
Initiates: Equal-Weight
Price Target: $245
Current: $258.35
Upside: -5.17%
Jun 24, 2025
Initiates: Overweight
Price Target: $150
Current: $119.75
Upside: +25.26%
Jun 24, 2025
Initiates: Overweight
Price Target: $55
Current: $45.60
Upside: +20.61%
Jun 24, 2025
Initiates: Overweight
Price Target: $1,325
Current: $1,276.10
Upside: +3.83%
May 8, 2025
Upgrades: Overweight
Price Target: $11 → $14
Current: $11.55
Upside: +21.21%
May 1, 2025
Maintains: Overweight
Price Target: $55 → $60
Current: $55.40
Upside: +8.30%
Apr 10, 2025
Maintains: Equal-Weight
Price Target: $400 → $350
Current: $303.08
Upside: +15.48%
Apr 10, 2025
Maintains: Overweight
Price Target: $58 → $45
Current: $27.08
Upside: +66.17%
Apr 10, 2025
Maintains: Overweight
Price Target: $140 → $110
Current: $85.28
Upside: +28.99%